Furthermore, we suggested an alternative and promising target for IPF treatment by showing that ATII cell–mediated chemotaxis and fibrosis induction could be blocked by the selective inhibition of p300 activity or stability. This evidence concerns the gene EP300 and idiopathic interstitial pneumonia.